Market Tracker

07/26 5:16pm ET

Transition Therapeutics Inc (NASDAQ:TTHI)

1.62
Delayed Data
As of Jul 26
 +0.03 / +1.89%
Today’s Change
0.66
Today|||52-Week Range
2.75
-15.62%
Year-to-Date
No recent news for Transition Therapeutics Inc.

Today’s Trading

Previous close1.59
Today’s open1.58
Day’s range1.58 - 1.62
Volume33,375
Average volume (3 months)88,081
Market cap$61.8M
Dividend yield--
Data as of 3:28pm ET, 07/26/2016

Growth & Valuation

Earnings growth (last year)-78.76%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book2.10

Competitors

 Today’s
change
Today’s
% change
CALACalithera Bioscience...+0.06+1.89%
TRILTrillium Therapeutic...-0.02-0.23%
GALTGalectin Therapeutic...+0.00+0.32%
CGIXCancer Genetics Inc+0.03+1.49%
Data as of 3:59pm ET, 07/26/2016

Financials

Next reporting dateSeptember 13, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$43.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Tony F. Cruz
President &
Chief Operating Officer
Carl Damiani
Corporate headquarters
Toronto, Ontario

Forecasts